VISHEE(SH:688580) Xin Lang Zheng Quan·2026-01-13 02:50Company Overview - Nanjing Weisi Medical Technology Co., Ltd. was established on January 10, 2001, and went public on July 21, 2020. The company specializes in the research, development, production, and sales of rehabilitation medical devices, focusing on innovative solutions in areas such as pelvic floor and postpartum rehabilitation, neurological rehabilitation, and mental rehabilitation [2]. Business Performance - For the period from January to September 2025, Weisi Medical achieved operating revenue of 326 million yuan, representing a year-on-year growth of 11.58%. The net profit attributable to the parent company was 102 million yuan, with a year-on-year increase of 30.68% [2]. - The company's main business revenue composition includes: magnetic stimulation (39.44%), consumables and accessories (19.42%), electrophysiology (19.18%), laser radiofrequency (10.26%), electrical stimulation (8.42%), and others (3.28%) [2]. Stock Performance - As of January 13, Weisi Medical's stock price was 65.00 yuan per share, with a market capitalization of 6.225 billion yuan. The stock has increased by 34.30% year-to-date, but has decreased by 6.74% over the past five trading days [1]. - The company has appeared on the trading leaderboard once this year, with the most recent appearance on January 6, where it recorded a net buy of -20.278 million yuan [1]. Dividend Information - Weisi Medical has distributed a total of 386 million yuan in dividends since its A-share listing, with 226 million yuan distributed over the past three years [3].